These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7133428)

  • 1. [Evaluation of a long-acting hydroquinidine preparation].
    Guffanti E; Vaccarella A; Meregalli M
    Minerva Cardioangiol; 1982; 30(7-8):381-5. PubMed ID: 7133428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
    Fazio S; Villari B; Petitto M; Santomauro M; Iacono C; Celentano A; de Divitiis O
    Minerva Cardioangiol; 1987 Nov; 35(11):631-6. PubMed ID: 3444537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dihydroquinidine metabolites after the administration in man of a delayed-action preparation].
    Flouvat B; Resplandy G; Roux A; Friocourt P; Viel C; Plat M
    Therapie; 1988; 43(4):255-61. PubMed ID: 3187925
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new anti-arrhythmic agent: a prolonged-action derivative of quinidine].
    Warembourg H; Ducloux G
    Lille Med; 1971 Jan; 16():Suppl 1:234-7. PubMed ID: 5162045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the efficacy of 2 delayed-action preparations of hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia].
    Lévy S; Moyal C; Dolla E; Cointe R; Bru P; Lauribe P; Paganelli F; Chanu P; Gérard R
    Arch Mal Coeur Vaiss; 1993 Sep; 86(9):1359-63. PubMed ID: 8129554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of rhythm disorders by a new quinidine salt with sustained-action: study of quinidinemia (apropos of 45 cases)].
    Salvador M; Fauvel JM; Lesbre JP; Galinier F
    Arch Mal Coeur Vaiss; 1971 May; 64(5):712-26. PubMed ID: 4998225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics and efficacy of delayed-action hydroquinidine in patients with ventricular extrasystole].
    Victor J; Turcant A; Tadei A; Allain P
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):163-6. PubMed ID: 2436547
    [No Abstract]   [Full Text] [Related]  

  • 8. Short- and long-acting oral quinidine preparations: clinical implications of pharmacokinetic differences.
    Woo E; Greenblatt DJ; Ochs HR
    Angiology; 1978 Mar; 29(3):243-50. PubMed ID: 646185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arrhythmia with quinidine duriles].
    Ernst S
    Ther Ggw; 1970 Jul; 109(7):1019-36. PubMed ID: 5469934
    [No Abstract]   [Full Text] [Related]  

  • 10. Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant.
    Pirro E; De Francia S; Banaudi E; Riggi C; De Martino F; Piccione FM; Giustetto C; Racca S; Agnoletti G; Di Carlo F
    Br J Clin Pharmacol; 2011 Dec; 72(6):982-4. PubMed ID: 21707701
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative clinical evaluation of two salts of quinidine using 24-hour Holter monitor recordings.
    Thompson EJ; Marwaha R; Naik G
    Angiology; 1978 Mar; 29(3):251-9. PubMed ID: 77140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of quinidine short and long-acting in control of arrhythmias.
    Coodley E; Pugash N; Toppo F
    Angiology; 1984 Sep; 35(9):581-90. PubMed ID: 6486521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quinidine arabogalactane-sulfate efficiency duration estimate using Holter monitor recording (author's transl)].
    Normand JP; Maspoli JJ; Jarreau C; Schwob J; Collignon I
    Therapie; 1981; 36(5):547-54. PubMed ID: 7323993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration].
    Flouvat B; Delhotal B; Kahn JC; Crouzette J; Dubourg O; Roux A; Fodor F; Bourdarias JP
    Therapie; 1984; 39(4):337-44. PubMed ID: 6484877
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic results with the combination preparation Phenrytmat in cardiology].
    Päuser H
    Z Allgemeinmed; 1975 Mar; 51(7):333-4. PubMed ID: 3033
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new long acting quinidine preparation].
    Heulin A; Delvaux JC; Vacheron A
    Coeur Med Interne; 1975; 14(1):145-6. PubMed ID: 1091404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the electrophysiological properties of atenolol and of the combination of quinidine and atenolol in humans].
    Capucci A; Verardi P; Binetti G; Bracchetti D; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1979; 24(10):1059-64. PubMed ID: 261887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of recurrent ventricular tachycardia with hydroquinidine. Evaluation of its efficacy with electrophysiological technics].
    Lévy S; Cointe R; Metge M; Faugère G; Valeix B; Gérard R
    Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1346-52. PubMed ID: 3936438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.